DNASE1 | Deoxyribonuclease I | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Group enriched |
SPTB | Spectrin, beta, erythrocytic | Disease related genes Plasma proteins
| | | | | Group enriched |
SYP | Synaptophysin | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
TMEM40 | Transmembrane protein 40 | Predicted membrane proteins
| | | | | Group enriched |
AHNAK2 | AHNAK nucleoprotein 2 | Cancer-related genes
| | | | | Tissue enriched |
CLDN16 | Claudin 16 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
GLDC | Glycine dehydrogenase (decarboxylating) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Group enriched |
KRT5 | Keratin 5 | Disease related genes Plasma proteins
| | | | | Group enriched |
MEST | Mesoderm specific transcript | Predicted secreted proteins
| | | | | Tissue enriched |
PPBP | Pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PVALB | Parvalbumin | | | | | | Group enriched |
RAB11FIP3 | RAB11 family interacting protein 3 (class II) | Cancer-related genes
| | | | | Tissue enriched |
STXBP1 | Syntaxin binding protein 1 | Disease related genes Plasma proteins
| | | | | Tissue enriched |
TUBB2A | Tubulin, beta 2A class IIa | | | | | | Tissue enriched |
UCHL1 | Ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ANPEP | Alanyl (membrane) aminopeptidase | CD markers Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
C4BPA | Complement component 4 binding protein, alpha | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | | Group enriched |
FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
FHL2 | Four and a half LIM domains 2 | | | | | | Group enriched |
KHDRBS3 | KH domain containing, RNA binding, signal transduction associated 3 | | | | | | Group enriched |
PLCB3 | Phospholipase C, beta 3 (phosphatidylinositol-specific) | Enzymes
| | | | | Group enriched |
SATB2 | SATB homeobox 2 | Disease related genes Transcription factors
| | | | | Group enriched |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
ZNF106 | Zinc finger protein 106 | Plasma proteins
| | | | | Group enriched |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
AK4 | Adenylate kinase 4 | Enzymes Mitochondrial proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AKR1C2 | Aldo-keto reductase family 1, member C2 | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
ALDH1A3 | Aldehyde dehydrogenase 1 family, member A3 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
AQP3 | Aquaporin 3 (Gill blood group) | Blood group antigen proteins Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ASS1 | Argininosuccinate synthase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
BAG2 | BCL2-associated athanogene 2 | Plasma proteins
| | | | | Tissue enhanced |
BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
C1orf116 | Chromosome 1 open reading frame 116 | | | | | | Tissue enhanced |
CA14 | Carbonic anhydrase XIV | Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | Cancer-related genes
| | | | | Tissue enhanced |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CCSAP | Centriole, cilia and spindle-associated protein | | | | | | Tissue enhanced |
CD247 | CD247 molecule | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD3E | CD3e molecule, epsilon (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CD48 | CD48 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD6 | CD6 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD69 | CD69 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CDC25C | Cell division cycle 25C | Cancer-related genes Enzymes
| | | | | Tissue enhanced |